Breakthrough gene therapy allows 11-year-old boy to hear for the first time
Aissam Dam, an 11-year-old boy born deaf, underwent a successful clinical trial for gene therapy to treat his congenital deafness. The therapy aims to replace the mutated otoferlin gene with a functional one. This groundbreaking study, supported by Eli Lilly, could pave the way for gene therapies targeting other forms of congenital deafness.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
